https://www.selleckchem.com/pr....oducts/Sunitinib-Mal
Herein, we review both laboratory and clinical evidence that support the utility of apoptotic cell-based therapies in prevention and treatment of graft versus host disease and transplant rejection along with induction of donor-specific tolerance in solid organ transplantation. We have highlighted the potential limitations and challenges of this apoptotic donor cell-based therapy together with ongoing advancements and attempts made to overcome them.Introduction Hyper-IgE Syndrome (HIES) is a rare inborn error of immunit
Like
Comment
Share
